What type of company is Kyowa Kirin?
Kyowa Kirin Co., Ltd. is a global specialty biopharmaceutical enterprise headquartered in Tokyo, Japan, operating as a core subsidiary of the Kirin Holdings group. The company focuses on the research, development, and commercialization of innovative antibody-based medicines, leveraging cutting-edge biotechnology platforms to create breakthrough therapeutics in targeted medical fields such as oncology, nephrology, immunology, and rare diseases. By advancing its proprietary research pipeline through global clinical trials, Kyowa Kirin strives to deliver life-changing medical solutions that address critical unmet health needs and improve patient outcomes internationally.
Related FAQs
Kyowa Kirin Co., Ltd. is a major Japanese multinational specialty pharmaceutical enterprise focused on discovering, developing, and commercializing innovative antibody-based medicines targeting therapeutic areas with high unmet medical needs.
The name L3Harris, a technology company specializing in aerospace and defense, is pronounced by combining the letter and number "L3" with the name "Harris." You say "L" as "ell," then the number "three," then "Harris," which is pronounced "HAIR-iss.
Kyowa Kirin operates as a highly respected, research-driven global specialty pharmaceutical enterprise renowned for its pioneering scientific developments in antibody engineering and biotechnology.
New Jersey is widely recognized as the pharmaceutical capital of the United States, frequently earning the moniker of the medicine chest of the world due to its extraordinarily dense concentration of global life sciences, biotechnology, and major pha...
Kyowa Kirin, Inc., the primary United States subsidiary and regional operational hub of the global specialty pharmaceutical enterprise Kyowa Kirin Co., Ltd., has its corporate headquarters located in Princeton, New Jersey, United States.
Asahi is not originally a Filipino brand, maintaining deep corporate roots and heritage as a globally renowned Japanese industrial and consumer goods enterprise, particularly famous for its historic beverage operations and electronics manufacturing.
The name Kyowa originates from the Japanese language, where it is written using kanji characters that typically combine elements meaning "cooperation," "harmony," or "union" (kyo) and "peace" or "Japan" (wa).
Employee reviews and workplace evaluations for Kyowa Kirin consistently highlight a collaborative, science-driven corporate culture centered on medical innovation, employee well-being, and professional growth.
The Japanese proper name Kyowa is a traditional compound word formed from kanji characters that translate directly to cooperation, harmony, mutual agreement, or unity.
Kyowa Kirin develops and manufactures innovative specialty pharmaceuticals focusing primarily on oncology, nephrology, immunology, and bone metabolism through advanced antibody engineering technologies.
Daiichi Sankyo Company, Limited is widely recognized as the second largest pharmaceutical enterprise in Japan, trailing only Takeda Pharmaceutical in total market capitalization and revenue generation.
Lamar Advertising Company (NASDAQ: LAMR) commands a corporate market capitalization and enterprise valuation of approximately $16.18 billion USD.
Lake Elmo Bank is an established traditional community financial institution maintaining an asset base scaling into hundreds of millions of dollars.
Kyowa Kirin Co., Ltd.